Ethypharm confirms completion of Altan acquisition
Acquisition14/10/2021
Ethypharm announced that its acquisition of Altan had completed and its employees had joined the group. The transaction established a direct presence in Spain and expanded the hospital injectables portfolio and research pipeline. Manuel Casegas was appointed to lead the Spanish affiliate, following his role in Altan’s industrial operations. The announcement described integration and continuity of operations within the wider Ethypharm group. The date records the public completion announcement, not an independently verified legal closing day. The release did not disclose the acquisition consideration or identify Ethypharm SAS as the direct buyer.
Type
Acquisition
Announced
14/10/2021
Amount
Financial data requires access